Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
701 Greene St
Ste 200
Augusta, GA 30901Phone+1 706-722-6900Fax+1 706-722-5118
Summary
- Mark Smith, MD is a nephrologist based in Augusta, GA. His educational background includes a Residency in Internal Medicine and Fellowship in Nephrology at the Medical College of Georgia, graduating from Ohio State University College of Medicine in 1992. He also held a certification as a Principal Investigator from ACRP from 2007 to 2018. Dr. Smith's areas of expertise include hypertension, general nephrology, transplant nephrology, glomerular disease, and dialysis. He has multiple publications in well-known medical journals such as the Journal of the American Society of Nephrology and Kidney Medicine, with significant citation counts.
Education & Training
ACRPCertified Principal Investigstor, 2007 - 2018
Medical College of GeorgiaFellowship, Nephrology, 1995 - 1997- Medical College of GeorgiaResidency, Internal Medicine, 1992 - 1995
Ohio State University College of MedicineClass of 1992
Certifications & Licensure
GA State Medical License 1993 - 2025
SC State Medical License 1996 - 2025
AK State Medical License 2024 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 38 citationsZiltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Tr...Pablo E. Pergola, Matt Devalaraja, Steven Fishbane, Michel Chonchol, Vandana Mathur
Journal of the American Society of Nephrology. 2021-01-01 - 11 citationsStaphylococcal Infection-Related Glomerulonephritis With Cryoglobulinemic Features.Mazdak A. Khalighi, Laith Al-Rabadi, Meghana Chalasani, Mark Smith, Siddhartha Kakani
Kidney International Reports. 2018-06-02 - 12 citationsA randomized, double-blind, placebo-controlled, dose-ranging study using Genz-644470 and sevelamer carbonate in hyperphosphatemic chronic kidney disease patients on he...Moustafa Moustafa, Lawrence Lehrner, Fahd Al-Saghir, Mark Smith, Sunita Goyal
International Journal of Nephrology and Renovascular Disease. 2014-04-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
